Literature DB >> 34979258

Myelin and non-myelin debris contribute to foamy macrophage formation after spinal cord injury.

Christine B Ryan1, James S Choi1, Hassan Al-Ali2, Jae K Lee3.   

Abstract

Tissue damage after spinal cord injury (SCI) elicits a robust inflammatory cascade that fails to resolve in a timely manner, resulting in impaired wound healing and cellular regeneration. This inflammatory response is partly mediated by infiltrating immune cells, including macrophages. As professional phagocytes, macrophages initially play an important role in debris clearance at the injury site, which would be necessary for proper tissue regeneration. After SCI, most macrophages become filled with lipid droplets due to excessive uptake of lipid debris, assuming a "foamy" phenotype that is associated with a proinflammatory state. Myelin has been assumed to be the main source of lipid that induces foamy macrophage formation after injury given its abundance in the spinal cord. This assumption has led to the widespread use of purified myelin treatment to model foamy macrophage formation in vitro. However, the assumption that myelin is necessary for foamy macrophage formation remains untested. To this end, we developed a novel foamy macrophage assay utilizing total spinal cord homogenate to include all sources of lipid present at the injury site. Using the myelin basic protein knockout (MBP KO, i.e., Shiverer) mice that lack myelin, we investigated lipid accumulation in foamy macrophages. Primary macrophages treated with myelin-deficient spinal cord homogenate still formed large lipid droplets typically observed in foamy macrophages, although to a lesser degree than cells treated with normal homogenate. Similarly, MBP KO mice subjected to contusive spinal cord injury also formed foamy macrophages that exhibited reduced lipid content and associated with improved histological outcomes and reduced immune cell infiltration. Therefore, the absence of myelin does not preclude foamy macrophage formation, indicating that myelin is not the only major source of lipid that contributes this pathology, even though myelin may alter certain aspects of its inflammatory profile.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammation; Lipids; Macrophages; Myeloid

Mesh:

Substances:

Year:  2021        PMID: 34979258      PMCID: PMC8783370          DOI: 10.1016/j.nbd.2021.105608

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  42 in total

1.  Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord.

Authors:  Kristina A Kigerl; John C Gensel; Daniel P Ankeny; Jessica K Alexander; Dustin J Donnelly; Phillip G Popovich
Journal:  J Neurosci       Date:  2009-10-28       Impact factor: 6.167

2.  Macrophages in spinal cord injury: phenotypic and functional change from exposure to myelin debris.

Authors:  Xi Wang; Kai Cao; Xin Sun; Yongxiong Chen; Zhaoxia Duan; Li Sun; Lei Guo; Paul Bai; Dongming Sun; Jianqing Fan; Xijing He; Wise Young; Yi Ren
Journal:  Glia       Date:  2014-11-28       Impact factor: 7.452

3.  Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide.

Authors:  L J van der Laan; S R Ruuls; K S Weber; I J Lodder; E A Döpp; C D Dijkstra
Journal:  J Neuroimmunol       Date:  1996-11       Impact factor: 3.478

4.  Brain lipid composition of the shiverer mouse: (genetic defect in myelin development).

Authors:  T D Bird; D F Farrell; S M Sumi
Journal:  J Neurochem       Date:  1978-07       Impact factor: 5.372

5.  Nonphlogistic clearance of late apoptotic neutrophils by macrophages: efficient phagocytosis independent of beta 2 integrins.

Authors:  Y Ren; L Stuart; F P Lindberg; A R Rosenkranz; Y Chen; T N Mayadas; J Savill
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

6.  Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species.

Authors:  Yang Liu; Wenlin Hao; Maryse Letiembre; Silke Walter; Miroslav Kulanga; Harald Neumann; Klaus Fassbender
Journal:  J Neurosci       Date:  2006-12-13       Impact factor: 6.167

7.  Biochemical abnormalities in spinal cord myelin and CNS homogenates in heterozygotes affected by the shiverer mutation.

Authors:  W Cammer; S Kahn; T Zimmerman
Journal:  J Neurochem       Date:  1984-05       Impact factor: 5.372

8.  Activating Adiponectin Signaling with Exogenous AdipoRon Reduces Myelin Lipid Accumulation and Suppresses Macrophage Recruitment after Spinal Cord Injury.

Authors:  Qishuang Zhou; Hongkai Xiang; Ang Li; Wu Lin; Zhaoshui Huang; Junxiu Guo; Pingjie Wang; Yijie Chi; Ke Xiang; Yunsheng Xu; Libing Zhou; Kwok-Fai So; Xiaoming Chen; Xin Sun; Yi Ren
Journal:  J Neurotrauma       Date:  2018-10-30       Impact factor: 5.269

9.  Single-cell analysis of the cellular heterogeneity and interactions in the injured mouse spinal cord.

Authors:  Lindsay M Milich; James S Choi; Christine Ryan; Susana R Cerqueira; Sofia Benavides; Stephanie L Yahn; Pantelis Tsoulfas; Jae K Lee
Journal:  J Exp Med       Date:  2021-06-16       Impact factor: 14.307

10.  The effects of myelin on macrophage activation are phenotypic specific via cPLA2 in the context of spinal cord injury inflammation.

Authors:  Timothy J Kopper; Bei Zhang; William M Bailey; Kara E Bethel; John C Gensel
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

View more
  1 in total

1.  Bioinformatics analysis identified apolipoprotein E as a hub gene regulating neuroinflammation in macrophages and microglia following spinal cord injury.

Authors:  Xin-Qiang Yao; Jia-Ying Chen; Zi-Han Yu; Zu-Cheng Huang; Regan Hamel; Yong-Qiang Zeng; Zhi-Ping Huang; Ke-Wu Tu; Jun-Hao Liu; Yan-Meng Lu; Zhi-Tao Zhou; Stefano Pluchino; Qing-An Zhu; Jian-Ting Chen
Journal:  Front Immunol       Date:  2022-08-24       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.